Jan 8 (Reuters) - Windtree Therapeutics Inc WINT.O:
WINDTREE THERAPEUTICS ANNOUNCES NEW CORPORATE STRATEGY SEEKING TO IDENTIFY AND ACQUIRE FDA-APPROVED REVENUE ASSETS WHILE ADVANCING ITS CARDIOVASCULAR AND ONCOLOGY PIPELINE
WINDTREE THERAPEUTICS INC - TO ACQUIRE STRATEGIC SUBSIDIARIES WITH FDA-APPROVED PRODUCTS
WINDTREE THERAPEUTICS INC - TO USE EQUITY FOR ACQUISITIONS
Source text: nGNX15G7l0
Further company coverage: WINT.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.